We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Brown Fat Hormone Signaling Prevents Obesity by Modulating Liver Lipid Metabolism

By LabMedica International staff writers
Posted on 25 Nov 2014
Print article
A hormone produced by brown adipose tissue has been determined to modulate the activity of liver cells that metabolize sugar into fats and is apparently linked to the development of metabolic disorders such as type II diabetes, nonalcoholic fatty liver disease, and obesity.

Investigators at the University of Michigan (Ann Arbor, USA) worked with genetically engineered mice in which the production of the hormone neuregulin 4 (Nrg4) was either blocked or enhanced. The neuregulins, including NRG4, activate type-1 growth factor receptors to initiating cell-to-cell signaling through tyrosine phosphorylation.

In a paper published in the November 17, 2014, online edition of the journal Nature Medicine, the investigators reported that Nrg4 was highly expressed in adipose tissues, enriched in brown fat, and markedly increased during brown adipocyte differentiation. Adipose tissue Nrg4 expression was reduced in rodent and human obesity. Gain- and loss-of-function studies in genetically engineered mice demonstrated that Nrg4 protected against diet-induced insulin resistance and accumulation of fats in the liver by reducing lipogenic signaling.

Mice genetically engineered to lack the gene for NRG4 became obese and developed symptoms of type II diabetes and fatty liver disease. Animals in which NRG4 levels were genetically elevated were protected from these metabolic disorders when fed a high-calorie, high-fat diet.

Senior author Dr. Jiandie Lin, associate professor of cell and developmental biology at the University of Michigan, said, "In all models of obesity, NRG4 expression is reduced. We think obesity is a state of NRG4 deficiency. Realistically, there are still many challenges to figuring out how it acts in the body and might be used as a drug, but in general, we know that NRG4 is beneficial for body metabolism and are excited about its potential."

Related Links:

University of Michigan


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Unit-Dose Packaging solution
HLX
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.